List of Excipients in API spironolactone
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing spironolactone
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | ALDACTONE | spironolactone | 0025-1001 | CALCIUM SULFATE DIHYDRATE | |
| Pfizer Laboratories Div Pfizer Inc | ALDACTONE | spironolactone | 0025-1001 | CARNAUBA WAX | |
| Pfizer Laboratories Div Pfizer Inc | ALDACTONE | spironolactone | 0025-1001 | FERRIC OXIDE RED | |
| Pfizer Laboratories Div Pfizer Inc | ALDACTONE | spironolactone | 0025-1001 | HYPROMELLOSE 2910 | |
| Pfizer Laboratories Div Pfizer Inc | ALDACTONE | spironolactone | 0025-1001 | MAGNESIUM STEARATE | |
| Pfizer Laboratories Div Pfizer Inc | ALDACTONE | spironolactone | 0025-1001 | PEPPERMINT | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing spironolactone
Detailed excipient profiles for spironolactone
Excipient focus: ALUMINUM OXIDE
spironolactone drug variants containing ALUMINUM OXIDE
spironolactone drug variants not containing ALUMINUM OXIDE
Excipient focus: AMMONIUM GLYCYRRHIZATE
spironolactone drug variants containing AMMONIUM GLYCYRRHIZATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| Amneal Pharmaceuticals NY LLC | spironolactone | 69238-2027 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing AMMONIUM GLYCYRRHIZATE
Excipient focus: AMMONIUM LAURETH-5 SULFATE
spironolactone drug variants containing AMMONIUM LAURETH-5 SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Cardinal Health 107 LLC | spironolactone | 55154-5517 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing AMMONIUM LAURETH-5 SULFATE
Excipient focus: ANHYDROUS CITRIC ACID
spironolactone drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: ANHYDROUS LACTOSE
spironolactone drug variants containing ANHYDROUS LACTOSE
spironolactone drug variants not containing ANHYDROUS LACTOSE
Excipient focus: CALCIUM SULFATE
spironolactone drug variants containing CALCIUM SULFATE
spironolactone drug variants not containing CALCIUM SULFATE
Excipient focus: CALCIUM SULFATE DIHYDRATE
spironolactone drug variants containing CALCIUM SULFATE DIHYDRATE
spironolactone drug variants not containing CALCIUM SULFATE DIHYDRATE
Excipient focus: CARNAUBA WAX
spironolactone drug variants containing CARNAUBA WAX
spironolactone drug variants not containing CARNAUBA WAX
Excipient focus: CELLULOSE, MICROCRYSTALLINE
spironolactone drug variants containing CELLULOSE, MICROCRYSTALLINE
spironolactone drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CROSCARMELLOSE SODIUM
spironolactone drug variants containing CROSCARMELLOSE SODIUM
spironolactone drug variants not containing CROSCARMELLOSE SODIUM
Excipient focus: CROSPOVIDONE
spironolactone drug variants containing CROSPOVIDONE
spironolactone drug variants not containing CROSPOVIDONE
Excipient focus: D&C YELLOW NO. 10
spironolactone drug variants containing D&C YELLOW NO. 10
spironolactone drug variants not containing D&C YELLOW NO. 10
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
spironolactone drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone and hydrochlorothiazide | 0378-0403 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: DEXTROSE
spironolactone drug variants containing DEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | spironolactone | 42254-183 |
| State of Florida DOH Central Pharmacy | spironolactone | 53808-0796 |
| Physicians Total Care Inc | spironolactone | 54868-0700 |
| Carilion Materials Management | spironolactone | 68151-2776 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing DEXTROSE
Excipient focus: DIBASIC CALCIUM PHOSPHATE DIHYDRATE
spironolactone drug variants containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
spironolactone drug variants not containing DIBASIC CALCIUM PHOSPHATE DIHYDRATE
Excipient focus: DIMETHICONE
spironolactone drug variants containing DIMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| Amneal Pharmaceuticals NY LLC | spironolactone | 69238-2027 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing DIMETHICONE
Excipient focus: DOCUSATE SODIUM
spironolactone drug variants containing DOCUSATE SODIUM
spironolactone drug variants not containing DOCUSATE SODIUM
Excipient focus: FD&C YELLOW NO. 6
spironolactone drug variants containing FD&C YELLOW NO. 6
spironolactone drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
spironolactone drug variants containing FERRIC OXIDE RED
spironolactone drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
spironolactone drug variants containing FERRIC OXIDE YELLOW
spironolactone drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
spironolactone drug variants containing FERROSOFERRIC OXIDE
spironolactone drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: GLYCERIN
spironolactone drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| Amneal Pharmaceuticals NY LLC | spironolactone | 69238-2027 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing GLYCERIN
Excipient focus: HYDROXYPROPYL CELLULOSE
spironolactone drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone and hydrochlorothiazide | 0025-1011 |
| Greenstone LLC | spironolactone and hydrochlorothiazide | 59762-5014 |
| Prasco Laboratories | spironolactone and hydrochlorothiazide | 66993-188 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
spironolactone drug variants containing HYPROMELLOSE
spironolactone drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2910
spironolactone drug variants containing HYPROMELLOSE 2910
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Mylan Pharmaceuticals Inc | spironolactone | 0378-2146 |
| Mylan Institutional Inc | spironolactone | 51079-103 |
| Greenstone LLC | spironolactone | 59762-5011 |
| Bryant Ranch Prepack | spironolactone | 72162-2150 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
spironolactone drug variants containing HYPROMELLOSES
spironolactone drug variants not containing HYPROMELLOSES
Excipient focus: LACTOSE
spironolactone drug variants containing LACTOSE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | spironolactone and hydrochlorothiazide | 54868-0699 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing LACTOSE
Excipient focus: LACTOSE MONOHYDRATE
spironolactone drug variants containing LACTOSE MONOHYDRATE
spironolactone drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
spironolactone drug variants containing MAGNESIUM STEARATE
spironolactone drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| Amneal Pharmaceuticals NY LLC | spironolactone | 69238-2027 |
| >Company | >Ingredient | >NDC |
Excipient focus: MALIC ACID
spironolactone drug variants containing MALIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals NY LLC | spironolactone | 69238-2027 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing MALIC ACID
Excipient focus: MALTODEXTRIN
spironolactone drug variants containing MALTODEXTRIN
| Company | Ingredient | NDC |
|---|---|---|
| Rebel Distributors Corp | spironolactone | 42254-183 |
| State of Florida DOH Central Pharmacy | spironolactone | 53808-0796 |
| Physicians Total Care Inc | spironolactone | 54868-0700 |
| Carilion Materials Management | spironolactone | 68151-2776 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing MALTODEXTRIN
Excipient focus: MENTHOL
spironolactone drug variants containing MENTHOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone and hydrochlorothiazide | 0378-0403 |
| Mylan Institutional Inc | spironolactone and hydrochlorothiazide | 42292-017 |
| Physicians Total Care Inc | spironolactone and hydrochlorothiazide | 54868-0699 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing MENTHOL
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
spironolactone drug variants containing MICROCRYSTALLINE CELLULOSE 101
spironolactone drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
spironolactone drug variants containing MICROCRYSTALLINE CELLULOSE 102
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | spironolactone and hydrochlorothiazide | 0378-0403 |
| Mylan Institutional Inc | spironolactone and hydrochlorothiazide | 42292-017 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: MINT
spironolactone drug variants containing MINT
spironolactone drug variants not containing MINT
Excipient focus: PEPPERMINT
spironolactone drug variants containing PEPPERMINT
spironolactone drug variants not containing PEPPERMINT
Excipient focus: PEPPERMINT OIL
spironolactone drug variants containing PEPPERMINT OIL
spironolactone drug variants not containing PEPPERMINT OIL
Excipient focus: POLYDEXTROSE
spironolactone drug variants containing POLYDEXTROSE
spironolactone drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
spironolactone drug variants containing POLYETHYLENE GLYCOL
spironolactone drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3000
spironolactone drug variants containing POLYETHYLENE GLYCOL 3000
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | spironolactone | 50090-1292 |
| RPK Pharmaceuticals Inc | spironolactone | 53002-1707 |
| Preferred Pharmaceuticals Inc | spironolactone | 68788-7258 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POLYETHYLENE GLYCOL 3000
Excipient focus: POLYETHYLENE GLYCOL 3350
spironolactone drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Bryant Ranch Prepack | spironolactone | 71335-0966 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
spironolactone drug variants containing POLYETHYLENE GLYCOL 400
spironolactone drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 6000
spironolactone drug variants containing POLYETHYLENE GLYCOL 6000
spironolactone drug variants not containing POLYETHYLENE GLYCOL 6000
Excipient focus: POLYETHYLENE GLYCOL 8000
spironolactone drug variants containing POLYETHYLENE GLYCOL 8000
spironolactone drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYETHYLENE GLYCOLS
spironolactone drug variants containing POLYETHYLENE GLYCOLS
spironolactone drug variants not containing POLYETHYLENE GLYCOLS
Excipient focus: POLYSORBATE 80
spironolactone drug variants containing POLYSORBATE 80
spironolactone drug variants not containing POLYSORBATE 80
Excipient focus: POLYVINYL ALCOHOL
spironolactone drug variants containing POLYVINYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | spironolactone | 50090-1292 |
| RPK Pharmaceuticals Inc | spironolactone | 53002-1707 |
| Preferred Pharmaceuticals Inc | spironolactone | 68788-7258 |
| Bryant Ranch Prepack | spironolactone | 71335-0966 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POLYVINYL ALCOHOL
Excipient focus: POTASSIUM SORBATE
spironolactone drug variants containing POTASSIUM SORBATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| Amneal Pharmaceuticals NY LLC | spironolactone | 69238-2027 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POTASSIUM SORBATE
Excipient focus: POVIDONE
spironolactone drug variants containing POVIDONE
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Par Pharmaceutical | spironolactone | 0603-5763 |
| NorthStar Rx LLC | spironolactone | 16714-084 |
| Rebel Distributors Corp | spironolactone | 21695-960 |
| Rebel Distributors Corp | spironolactone | 42254-183 |
| QPharma Inc | spironolactone | 42708-101 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POVIDONE
Excipient focus: POVIDONE K25
spironolactone drug variants containing POVIDONE K25
spironolactone drug variants not containing POVIDONE K25
Excipient focus: POVIDONE K29/32
spironolactone drug variants containing POVIDONE K29/32
| Company | Ingredient | NDC |
|---|---|---|
| Carilion Materials Management | spironolactone | 68151-2776 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing POVIDONE K29/32
Excipient focus: POVIDONE K30
spironolactone drug variants containing POVIDONE K30
spironolactone drug variants not containing POVIDONE K30
Excipient focus: POVIDONES
spironolactone drug variants containing POVIDONES
spironolactone drug variants not containing POVIDONES
Excipient focus: SACCHARIN SODIUM
spironolactone drug variants containing SACCHARIN SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| Amneal Pharmaceuticals NY LLC | spironolactone | 69238-2027 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing SACCHARIN SODIUM
Excipient focus: SILICON DIOXIDE
spironolactone drug variants containing SILICON DIOXIDE
spironolactone drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM BENZOATE
spironolactone drug variants containing SODIUM BENZOATE
spironolactone drug variants not containing SODIUM BENZOATE
Excipient focus: SODIUM LAURYL SULFATE
spironolactone drug variants containing SODIUM LAURYL SULFATE
spironolactone drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
spironolactone drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
spironolactone drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SORBIC ACID
spironolactone drug variants containing SORBIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| Amneal Pharmaceuticals NY LLC | spironolactone | 69238-2027 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing SORBIC ACID
Excipient focus: STARCH, CORN
spironolactone drug variants containing STARCH, CORN
spironolactone drug variants not containing STARCH, CORN
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| NorthStar Rx LLC | spironolactone | 16714-084 |
| Rebel Distributors Corp | spironolactone | 21695-766 |
| Rebel Distributors Corp | spironolactone | 21695-960 |
| A-S Medication Solutions | spironolactone | 50090-0136 |
| A-S Medication Solutions | spironolactone | 50090-6408 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
spironolactone drug variants containing STEARIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Pfizer Laboratories Div Pfizer Inc | spironolactone | 0025-1001 |
| Greenstone LLC | spironolactone | 59762-5011 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing STEARIC ACID
Excipient focus: TALC
spironolactone drug variants containing TALC
spironolactone drug variants not containing TALC
Excipient focus: TITANIUM DIOXIDE
spironolactone drug variants containing TITANIUM DIOXIDE
spironolactone drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRAGACANTH
spironolactone drug variants containing TRAGACANTH
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals NY LLC | spironolactone | 69238-2027 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing TRAGACANTH
Excipient focus: TRIACETIN
spironolactone drug variants containing TRIACETIN
spironolactone drug variants not containing TRIACETIN
Excipient focus: TRISODIUM CITRATE DIHYDRATE
spironolactone drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
spironolactone drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| Amneal Pharmaceuticals NY LLC | spironolactone | 69238-2027 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing WATER
Excipient focus: XANTHAN GUM
spironolactone drug variants containing XANTHAN GUM
| Company | Ingredient | NDC |
|---|---|---|
| Padagis US LLC | spironolactone | 0574-1133 |
| >Company | >Ingredient | >NDC |
spironolactone drug variants not containing XANTHAN GUM
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - HIPAA-ready chat for life sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
